ThinkEquity Initiates Coverage On G Medical Innovations with Buy Rating, Announces Price Target of $4
Portfolio Pulse from richadhand@benzinga.com
ThinkEquity analyst Ashok Kumar initiates coverage on G Medical Innovations (NASDAQ:GMVD) with a Buy rating and announces a price target of $4.
June 20, 2023 | 2:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ThinkEquity analyst Ashok Kumar initiates coverage on G Medical Innovations with a Buy rating and a price target of $4.
The Buy rating and price target of $4 announced by ThinkEquity analyst Ashok Kumar for G Medical Innovations (GMVD) is likely to have a positive short-term impact on the stock price. Investors may consider this as a positive signal and potentially increase their interest in the stock, driving the price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100